Neuronal-specific domain stabilization

Target: ANK2 Composite Score: 0.550 Price: $0.51▼2.3% Citation Quality: 50% neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
✓ All Quality Gates Passed
Evidence Strength Moderate (50%)
6
Citations
1
Debates
6
Supporting
2
Opposing
Quality Report Card click to collapse
C+
Composite: 0.550
Top 56% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
B Mech. Plausibility 15% 0.60 Top 57%
C+ Evidence Strength 15% 0.55 Top 47%
C+ Novelty 12% 0.55 Top 75%
C+ Feasibility 12% 0.55 Top 58%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
B+ Reproducibility 5% 0.70 Top 24%
Evidence
6 supporting | 2 opposing
Citation quality: 0%
Debates
0 sessions
No debates yet
Convergence
0.00 F 30 related hypothesis share this target

Description

Axon initial segment (AIS) infrastructure provides additional regulatory context that consolidates MAP-established domains; in fibroblasts, domains are less stable without this architectural support

Prediction: Transplanting AIS components into fibroblasts will produce more robust and long-lasting tau/MAP6 domain segregation

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["MAPT/Tau Protein
Microtubule Stabilizer"] B["CDK5/GSK3B Activation
Kinase Dysregulation"] C["Tau Hyperphosphorylation
Ser396/Thr231/Ser202"] D["Tau Detachment
Microtubule Destabilized"] E["Tau Oligomers
Paired Helical Filaments"] F["Neurofibrillary Tangles
Intraneuronal Inclusions"] G["Axonal Transport Failure
Synaptic Dysfunction"] H["Neurodegeneration
Tauopathy Spread"] A --> B B --> C C --> D D --> E E --> F D --> G G --> H F --> H style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

GTEx v10 Brain Expression

JSON

Median TPM across 13 brain regions for ANK2 from GTEx v10.

Cerebellum75.4 Cerebellar Hemisphere70.9 Frontal Cortex BA945.6 Cortex38.5 Anterior cingulate cortex BA2434.7 Nucleus accumbens basal ganglia31.7 Hypothalamus27.0 Caudate basal ganglia24.4 Amygdala22.9 Substantia nigra19.9 Hippocampus19.5 Putamen basal ganglia18.6 Spinal cord cervical c-117.3median TPM (GTEx v10)

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.55 (12%) Feasibility 0.55 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.70 (5%) KG Connect 0.50 (8%) 0.550 composite
8 citations 7 with PMID 7 medium Validation: 0% 6 supporting / 2 opposing
For (6)
5
2
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
4
4
MECH 4CLIN 0GENE 4EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Autism-associated ANK2 regulates embryonic neurode…SupportingMECHBiochem Biophys… MEDIUM2022-PMID:35313230-
A Mutation in the ANK2 Gene Causing ASD and a Revi…SupportingGENEMol Genet Genom… MEDIUM2025-PMID:40035441-
Self-limited familial focal epilepsy caused by ANK…SupportingGENEEpilepsia Open MEDIUM2025-PMID:39962910-
Roles of ANK2/ankyrin-B in neurodevelopmental diso…SupportingMECHCurr Opin Neuro… MEDIUM2025-PMID:39631164-
ANK2 loss-of-function variants are associated with…SupportingGENEHum Mol Genet MEDIUM2023-PMID:37195288-
Ankyrin-G and AIS organization depend on many bind…OpposingMECHBiomolecules MEDIUM2025-PMID:40563541-
AIS abnormalities are emphasized in neurodevelopme…OpposingGENECells MEDIUM2021-PMID:34440880-
Axon initial segment (AIS) infrastructure provides…SupportingMECH------
Legacy Card View — expandable citation cards

Supporting Evidence 6

Axon initial segment (AIS) infrastructure provides additional regulatory context that consolidates MAP-establi…
Axon initial segment (AIS) infrastructure provides additional regulatory context that consolidates MAP-established domains; in fibroblasts, domains are less stable without this architectural support
Autism-associated ANK2 regulates embryonic neurodevelopment. MEDIUM
Biochem Biophys Res Commun · 2022 · PMID:35313230
A Mutation in the ANK2 Gene Causing ASD and a Review of the Literature. MEDIUM
Mol Genet Genomic Med · 2025 · PMID:40035441
Self-limited familial focal epilepsy caused by ANK2 variants: A potentially under-recognized condition. MEDIUM
Epilepsia Open · 2025 · PMID:39962910
Roles of ANK2/ankyrin-B in neurodevelopmental disorders: Isoform functions and implications for autism spectru… MEDIUM
Roles of ANK2/ankyrin-B in neurodevelopmental disorders: Isoform functions and implications for autism spectrum disorder and epilepsy.
Curr Opin Neurobiol · 2025 · PMID:39631164
ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plastic… MEDIUM
ANK2 loss-of-function variants are associated with epilepsy, and lead to impaired axon initial segment plasticity and hyperactive network activity in hiPSC-derived neuronal networks.
Hum Mol Genet · 2023 · PMID:37195288

Opposing Evidence 2

Ankyrin-G and AIS organization depend on many binding partners, making ANK2-only domain stabilization an incom… MEDIUM
Ankyrin-G and AIS organization depend on many binding partners, making ANK2-only domain stabilization an incomplete model of neuronal compartment maintenance.
Biomolecules · 2025 · PMID:40563541
AIS abnormalities are emphasized in neurodevelopmental disorders, so evidence for direct neurodegenerative the… MEDIUM
AIS abnormalities are emphasized in neurodevelopmental disorders, so evidence for direct neurodegenerative therapeutic relevance is indirect.
Cells · 2021 · PMID:34440880
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.

Price History

0.500.530.55 0.57 0.48 2026-04-252026-04-262026-04-27 Market PriceScoreevidencedebate 7 events
7d Trend
Stable
7d Momentum
▼ 2.3%
Volatility
High
0.0544
Events (7d)
7

Clinical Trials (1) Relevance: 65%

0
Active
0
Completed
0
Total Enrolled
Untitled Trial Unknown
Unknown ·

📚 Cited Papers (7)

No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
6

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.600

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for ANK2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ANK2 →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

Related Hypotheses

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
Score: 0.907 | neurodegeneration
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
Score: 0.895 | neurodegeneration
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
Score: 0.893 | neurodegeneration
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration
Score: 0.892 | neurodegeneration
Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State Transition Restoration
Score: 0.887 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions (2)

2 total 0 confirmed 0 falsified
IF we acutely disrupt AIS integrity in mature hippocampal neurons using pharmacological (sodium channel blocker) or genetic (ankyrin-G CRISPR knockout) approaches, THEN we will observe a >50% decrease in tau/MAP6 domain stability (measured by increased mobile fraction in FRAP and shorter domain lifetime) within 48-72 hours, compared to untreated neurons.
pending conf: 0.45
Expected outcome: Rapid destabilization of microtubule-associated protein domains following AIS disruption, evidenced by increased FRAP mobile fraction and decreased domain dwell time in live-cell imaging.
Falsified by: Domain stability metrics remain unchanged (within 10%) after AIS disruption, or domains become MORE stable, indicating AIS is not the primary architectural constraint for MAP domain maintenance in neurons.
Method: Dissociated mouse hippocampal neurons (DIV14-21) transfected with MAP6-eGFP, treated with 1μM tetrodotoxin or transfected with Cas9-sgAnkG for 48-72 hours, followed by FRAP analysis of AIS-localized MAP6 domains, with comparison to vehicle-treated or Cas9-sgLacZ controls.
IF we express the neuronal ANK2 isoform (ANK2-G) in human fibroblasts via lentiviral transduction, THEN we will observe a statistically significant increase in tau/MAP6 domain stability (measured by FRAP recovery half-time increasing by >40%) within 5-7 days post-transduction, compared to GFP-transduced control fibroblasts.
pending conf: 0.35
Expected outcome: Enhanced domain stability in fibroblasts expressing neuronal ANK2, manifested as slower fluorescence recovery in FRAP assays and reduced domain dissolution events over 72-hour imaging windows.
Falsified by: FRAP recovery half-times in ANK2-expressing fibroblasts remain statistically indistinguishable from control fibroblasts (p > 0.05), or domain stability metrics show <20% improvement, indicating AIS architecture alone is insufficient without additional neuronal-specific factors.
Method: Primary human dermal fibroblasts or iPSC-derived fibroblasts transduced with lenti-ANK2-G or lenti-GFP control, followed by FRAP analysis of mApple-tau or MAP6-mNeon domains at 5-7 days post-infection, with n≥30 cells per condition across 3 biological replicates.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 ANK2 — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for ANK2 structures...
Querying Protein Data Bank API

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (3)

Tau dysfunction destabilizes labile pool
Score: 0.75 · MAPT
Competition-based domain allocation
Score: 0.65 · MAPT
Domain boundary cross-talk hypothesis
Score: 0.60 · MAP6
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.